Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Montserrat
Montserrat Aldea Garcia, Madrid ES
| Patent application number | Description | Published |
|---|---|---|
| 20090169514 | Expression Vectors Comprising the HS1 Promoter of the VAV1 Oncogene and Use Thereof for the Preparation of Pharmaceutical Compositions Intended for Somatic Gene Therapy - The present invention relates to the use of the HS1 promoter of the vav oncogene in the production of vectors selected from the groups of integrative vectors and non-integrative, non-plasmid vectors, for use in the preparation of pharmaceutical compositions intended for somatic gene therapy. By generating vectors that contain the HS1 promoter of the vav oncogene, it was possible to generate vectors in which the marker transgene or therapeutic transgene is expressed at moderate, but stable, levels in various cell lines both in vitro and in vivo. | 07-02-2009 |
Montserrat Armengol Asparo, Sant Joan Despi ES
| Patent application number | Description | Published |
|---|---|---|
| 20080306279 | Synthesis Intermediates Useful For Preparing Zolmitriptan - In particular, this invention relates to the synthesis intermediates (IV), (V), (VI) and (VIII) useful for preparing zolmitriptanzohnitriptan or a pharmaceutically acceptable salt thereof, which includes a) Preparation of the diazonium salt of the aniline hydrochloride (II); followed by reduction and acidification to give hydrazine (III); b) In situ Reaction of the hydrazine hydrochloride (III) with α-keto-δ-valerolactone, to give the hydrazone (IV); c) Fischer indole synthesis of the hydrazone (IV), to give the pyranoindolone of formula (V); d) Transesterification of the pyranoindolone (V) to provide the compound (VI), in which R means a straight or branched C1-C4 alkyl; e) Conversion of the hydroxyl group of the compound (VI) into dimethylamino to give the indolecarboxylate (VII), in which R means a straight or branched C1-C4 alkyl; f) Saponification of the 2-carboalkoxy group of the compound (VII), to provide indolecarboxylic acid (VIII); g) Decarboxylation of the indolecarboxylic acid (VIII), to provide zolmitriptan and, eventually, to provide a pharmaceutically acceptable salt thereof. | 12-11-2008 |
Montserrat Bosch Gallego, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20110104205 | HETEROLOGOUS PROTECTION AGAINST PASTEURELLA MULTOCIDA PROVIDED BY P. MULTOCIDA FUR CELLS AND THE OUTER-MEMBRANE PROTEIN EXTRACTS THEREOF - The invention relates to | 05-05-2011 |
Montserrat Calleja Gomez, Madrid ES
| Patent application number | Description | Published |
|---|---|---|
| 20090207404 | System and Method for Surface Inspection of Micro- and Nanomechanical Structures - The system for surface inspection is arranged to detect relative displacement and/or vibration features of a plurality of points of a plurality of elements ( | 08-20-2009 |
Montserrat Calleja Gómez, Tres Cantos ES
| Patent application number | Description | Published |
|---|---|---|
| 20110039255 | METHOD AND SYSTEM FOR DETECTION OF A SELECTED TYPE OF MOLECULES IN A SAMPLE - The present invention refers to a method for detecting molecules and/or substances within a sample based on the use of a microcantilever system. The method comprises the variation of a certain condition such as humidity so as the mechanical feature analysed varies with a characteristic pattern while the target molecule is bound to the detector. The invention also refers to the system used to carry out such method. | 02-17-2011 |
Montserrat Calleja Gómez, Tres Cantos ES
| Patent application number | Description | Published |
|---|---|---|
| 20110039255 | METHOD AND SYSTEM FOR DETECTION OF A SELECTED TYPE OF MOLECULES IN A SAMPLE - The present invention refers to a method for detecting molecules and/or substances within a sample based on the use of a microcantilever system. The method comprises the variation of a certain condition such as humidity so as the mechanical feature analysed varies with a characteristic pattern while the target molecule is bound to the detector. The invention also refers to the system used to carry out such method. | 02-17-2011 |
Montserrat Costa Rierola, Parets Del Valles ES
| Patent application number | Description | Published |
|---|---|---|
| 20110027891 | MAMMALIAN CELL CULTURE MEDIA WHICH COMPRISE SUPERNATANT FROM COHN FRACTIONATION STAGES AND USE THEREOF - The present invention relates to mammalian cell culture media which comprise supernatant from some of the fractions of human plasma fractionation according to the Cohn method, more specifically, the supernatant of fractions I and II+III. When said supernatant is added as a culture medium supplement it provides various nutrients and factors for the effective maintenance and/or proliferation of the cultured mammalian cells. In addition, the present invention relates to the preparation process and use of said medium in the culture of mammalian cells. | 02-03-2011 |
Montserrat Erra Sola, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20100074898 | AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS - The present disclosure relates to compounds of formula (I): | 03-25-2010 |
| 20110212945 | AZABIPHENYLAMINOBENZOIC ACID DERIVATIVES AS DHODH INHIBITORS - The present disclosure relates to new azabiphenylaminobenzoic acid derivatives of formula (I); as well as processes for their preparation, pharmaceutical compositions comprising them, and their use in therapy as inhibitors of the dehydroorotate dihydrogenase (DHODH). | 09-01-2011 |
| 20110274657 | OXADIAZOLE DERIVATIVES AS S1P1 RECEPTOR ANTAGONISTS - The present disclosure relates to oxadiazole derivatives of formula (I) as well as pharmaceutical compositions comprising them, and their use in therapy as agonists of the S1P1 receptor. | 11-10-2011 |
| 20110311485 | 1,2,4-OXADIAZOLE DERIVATIVES AND THEIR THERAPEUTIC USE - The present disclosure relates to 1, 2, 4 oxadiazole derivatives of formula (I) as well as pharmaceutical compositions comprising them, and their use in therapy as agonists of the S1P1 receptors. | 12-22-2011 |
Montserrat Fernandez Balsells, Cerdanyola Del Valles ES
| Patent application number | Description | Published |
|---|---|---|
| 20090094764 | Glycol based pigmetnt preparation for mass dyeing of polyacrylonitrile fibers - The invention relates to a process for mass dyeing of polyacrylonitrile, wherein there is incorporated into a solution of acrylonitrile polymer or copolymer a pigment preparation which comprises | 04-16-2009 |
Montserrat Foguet Roca, Leverkusen DE
| Patent application number | Description | Published |
|---|---|---|
| 20090324727 | NANOEMULSION - The present invention relates to a nanoemulsion comprising at least one aqueous component and a carrier, wherein the carrier comprises at least one lipophilic component, at least one surfactant and at least one alcohol, characterised in that at least one alcohol has at least three carbon atoms. The present invention further relates to a composition comprising said nanoemulsion and an active agent. In particular, the composition is present as a gel and the active agent is 5-aminolevulinic acid, a derivative, precursor and/or metabolite thereof. The invention further relates to the preparation of said nanoemulsion and/or composition and to their use for the treatment of dermatological diseases, virus-associated diseases as well as diseases associated with cell proliferation, in particular, tumor diseases and/or psoriasis. The present invention is further directed to the use of said nanoemulsion in cosmetics. | 12-31-2009 |
| 20110250239 | PHARMACEUTICAL AND/OR COSMETIC COMPOSITION FOR TREATING THE SKIN - The present invention concerns the pharmaceutical and cosmetic application of biocolloids, which originate from the mixture of a nanoemulsion and at least one water-soluble plant extract such as an extract from | 10-13-2011 |
Montserrat Fontes Ustrell, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20100113420 | PYRROLOPYRIMIDINE DERIVATIVES AS JAK3 INHIBITORS - Pyrrolopyrimidine derivatives of Formula (I) that are useful as JAK3 kinase inhibitors. | 05-06-2010 |
| 20100204187 | Purine Derivatives - Purine derivatives of Formula (I), wherein the meanings for the various substituents are as disclosed in the description. These compounds are useful as JAK3 kinase inhibitors. | 08-12-2010 |
| 20110160185 | PYRROLOPYRIMIDINE DERIVATIVES AS JAK3 INHIBITORS - Pyrrolopyrimidine derivatives of Formula (I) that are useful as JAK3 kinase inhibitors. | 06-30-2011 |
Montserrat Miñarro Carmona, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20100159017 | COMPOSITION OF BIOCOMPATIBLE MICROPARTICLES OF ALGINIC ACID FOR THE CONTROLLED RELEASE OF ACTIVE INGREDIENTS BY INTRAVENOUS ADMINISTRATION - The invention relates to a biocompatible composition which comprises microparticles of alginic acid or its salts and an active ingredient. More particularly, the invention relates to microparticles for the encapsulation of an active ingredient to be administered intravenously to a patient who needs it. These microparticles are of a combination of size sufficient to increase the half-life or survival of the active ingredient in blood, with a low uptake in the liver and a fast cell clearance when administered intravenously. | 06-24-2010 |
Montserrat Miñarro Carmona, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20100159017 | COMPOSITION OF BIOCOMPATIBLE MICROPARTICLES OF ALGINIC ACID FOR THE CONTROLLED RELEASE OF ACTIVE INGREDIENTS BY INTRAVENOUS ADMINISTRATION - The invention relates to a biocompatible composition which comprises microparticles of alginic acid or its salts and an active ingredient. More particularly, the invention relates to microparticles for the encapsulation of an active ingredient to be administered intravenously to a patient who needs it. These microparticles are of a combination of size sufficient to increase the half-life or survival of the active ingredient in blood, with a low uptake in the liver and a fast cell clearance when administered intravenously. | 06-24-2010 |
Montserrat Monsalvatje Llagostera, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20080306270 | Process for the Preparation of a Leukotriene Antagonist and Intermediates Thereof - It comprises a preparation process of Montelukast from a new intermediate compound of formula (VI), which is previously prepared by reaction of the corresponding sulfonate with 1-(mercaptomethyl)cyclopropyl)methanol. Compound (VI) is reacted with a Grignard reactant to convert the ester group into a tertiary alcohol, followed by conversion of the primary alcohol into a sulfonate, substitution of the sulfonate group by a cyano group, and finally transforming the cyano compound to the carboxilic acid compound by a hydrolysis reaction to afford Montelukast. Montelukast can also be prepared by a hydrolysis reaction of the corresponding amide. It also comprises new intermediate compounds useful in such preparation process. | 12-11-2008 |
| 20090247759 | Purification process of Montelukast and its Amine Salts - It comprises a process for the purification of Montelukast, or its salts or its solvates, including any stereoisomer or mixture thereof, which comprises converting Montelukast acid or a solvate thereof, including any stereoisomer or mixtures thereof, into an amine salt selected from the group consisting of tris-(hydroxymethyl)aminomethane, L-(+)-treo-2-amino-1-phenyl-1,3-propanediol, and L-(+)-α-phenylglycinol salt, in the presence of an appropriate solvent. It also comprises novel salts of Montelukast, in particular, tris-(hydroxymethyl)aminomethane, L-(+)-treo-2-amino-1-phenyl-1,3-propanediol, and L-(+)-α-phenylglycinol salts. | 10-01-2009 |
| 20100029945 | Process for the purification of Montelukast - It relates to a process for the purification of Montelukast, or pharmaceutically salts thereof, or solvates thereof, including stereoisomers or mixture thereof which comprises carrying out a specific set of selective solvent extractions of Montelukast or its impurities in a mixture of an organic solvent and water at specific ranges of pH and temperature which depend on the type of impurities to remove. In particular, it comprises at least one wash of an aqueous phase containing crude Montelukast in salt form with an organic solvent, at a pH comprised between 12.0 and 13.5; and optionally one or more washes of the resulting aqueous phase with an organic solvent at a pH comprised between 8.5 and 10.0. Montelukast is recovered by acidification at a pH comprised between 4.5 and 8.0 and solvent extraction, and is isolated either as acid or in salt form. | 02-04-2010 |
Montserrat Najar Marton, Castelldefels (barcelona) ES
| Patent application number | Description | Published |
|---|---|---|
| 20110249703 | JOINT DEMODULATION AND SYNCHRONIZATION IN ULTRA WIDEBAND SYSTEMS - A method of demodulating at a receiver a plurality of symbols b | 10-13-2011 |
Montserrat Najar Marton, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20100020850 | METHOD FOR ESTIMATING THE TIME OF ARRIVAL IN ULTRA WIDEBAND SYSTEMS - Method and device for estimating the time-of-arrival of a received signal y(t), said method comprising the step of: generating a plurality of frequency-domain samples from the received signal y(t); estimating a correlation matrix (Formula I) from said plurality of frequency-domain samples; from said correlation matrix (Formula I), calculating a signal energy distribution with respect to different propagation delays; finding a delay value (Formula II) at which said signal energy distribution exceeds a certain threshold P | 01-28-2010 |
Montserrat Pages, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20110010794 | METHOD FOR IMPROVING PLANT TOLERANCE TO ENVIRONMENTAL STRESS - Provided are DNA sequences encoding a novel type of AP2 domain-containing transcription factor as well as methods for obtaining similar sequences. Also described are methods for obtaining plants with improved growth and enhanced stress tolerance, particularly tolerance to osmotic and dehydration stress, such methods comprising expression of such DNA sequences in a plant or parts thereof. Further described are diagnostic compositions comprising the aforementioned DNA sequences and the use of such sequences in plant breeding and/or agriculture. | 01-13-2011 |
Montserrat Riera Giner, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20110290905 | VOLATILE SUBSTANCE EVAPORATOR WITH SUBSTANCE END-OF-LIFE DETECTOR - The present invention generally relates to volatile substance evaporators having a container with wick, and has the object of providing a technique for effectively detecting end-of-life of the volatile substance housed within the container. The volatile substance evaporator is configured for coupling to, and maintaining in a stable position, a container of volatile substance having a wick with a lower end housed within said container and an upper end emerging from the container. The evaporator comprises an infrared light emitter disposed so as to emit a beam of light on said upper end of the wick, in such a manner that a receptor is disposed so as to capture said beam of light reflected by the upper end of the wick. | 12-01-2011 |
Montserrat Rivero Urgell, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20120077222 | Method and Device for Determining the Microbiological Contamination in an Environment - The method comprises providing at least one sampling plate and at least one supporting member in said environment with the supporting member being suitable for detachably receiving the sampling plate; and removing the plate from the supporting member after a period of time such that the microbiological contamination in said environment can be determined by analyzing said sampling plate. A device is provided for carrying out said method comprising the supporting member carrying one or more sampling plates, attaching means for detachably fixing the sampling plates therein and releasing means for removing of the sampling plate from the supporting member. | 03-29-2012 |
Montserrat Romero Font, Sant Hipolit De Voltrega ES
| Patent application number | Description | Published |
|---|---|---|
| 20110134522 | TILTING, RETRACTABLE SCREEN DEVICE FOR TABLES - Tilting, retractable screen device for tables, which comprises means for guiding the screen between a substantially vertical concealed position in which the screen is located under the surface of the table and a use position in which the screen projects from said surface, in which the guide means are configured in order to guide the table in a movement that takes the screen from the concealed position to a use position, which is tilted with respect to the surface of the table, said movement being composed of a vertical translation until the screen projects substantially from the surface, followed by a rotation that takes the screen to the use position, such that same may be used when tilted but remains vertical when stowed. | 06-09-2011 |
Montserrat Soler Lopez, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20100240656 | COMPOUNDS AS HSP90 INHIBITORS - The invention provides novel compounds of formula (I) wherein: one of the a, b, c or d members is a nitrogen atom and the remaining members are carbon atoms; and R | 09-23-2010 |
| 20110105544 | CARBOXYLIC DERIVATIVES FOR USE IN THE TREATMENT OF CANCER - The invention provides novel compounds of formula (I), wherein: R | 05-05-2011 |